OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Computational design of a neutralizing antibody with picomolar binding affinity for all concerning SARS-CoV-2 variants
Bo-Seong Jeong, Jeong Ho Seok, Insu Hwang, et al.
mAbs (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 12

Showing 12 citing articles:

Computational electrostatic engineering of nanobodies for enhanced SARS−CoV−2 receptor binding domain recognition
Zafar Iqbal, Muhammad Asim, Umair Khan, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access

Computational Protein Design for COVID-19 Research and Emerging Therapeutics
Parismita Kalita, Timir Tripathi, Aditya K. Padhi
ACS Central Science (2023) Vol. 9, Iss. 4, pp. 602-613
Open Access | Times Cited: 15

Lessons Learnt from COVID-19: Computational Strategies for Facing Present and Future Pandemics
Matteo Pavan, Stefano Moro
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4401-4401
Open Access | Times Cited: 13

An Overview of the Conventional and Novel Methods Employed for SARS-CoV-2 Neutralizing Antibody Measurement
Vinícius Pinto Costa Rocha, Helenita Costa Quadros, Antônio Márcio Santana Fernandes, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1504-1504
Open Access | Times Cited: 8

From De Novo Design to Redesign: Harnessing Computational Protein Design for Understanding SARS-CoV-2 Molecular Mechanisms and Developing Therapeutics
Aditya K. Padhi, Parismita Kalita, Shweata Maurya, et al.
The Journal of Physical Chemistry B (2023) Vol. 127, Iss. 41, pp. 8717-8735
Closed Access | Times Cited: 5

Design of human ACE2 mimic miniprotein binders that interact with RBD of SARS-CoV-2 variants of concerns
Neeraj Gaur, Zeenat Khakerwala, Ravindra D. Makde
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-13
Closed Access | Times Cited: 1

Nanobody-peptide-conjugate (NPC) for passive immunotherapy against SARS-CoV-2 variants of concern (VoC): a prospective pan-coronavirus therapeutics
Mamta Panda, Elora Kalita, Satyendra Singh, et al.
Molecular Diversity (2022) Vol. 27, Iss. 6, pp. 2577-2603
Open Access | Times Cited: 8

An optimized thermodynamics integration protocol for identifying beneficial mutations in antibody design
Zizhang Sheng, Jude Bimela, Maple Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2

The paradigm of immune escape by SARS-CoV-2 variants and strategies for repositioning subverted mAbs against escaped VOCs
Masaud Shah, Hyun Goo Woo
Molecular Therapy (2022) Vol. 30, Iss. 10, pp. 3101-3105
Open Access | Times Cited: 4

Isolation of SARS-CoV-2-blocking recombinant antibody fragments and characterisation of their binding to variant spike proteins
Delphine Antoine, Moein Mohammadi, Chloe E. McDermott, et al.
Frontiers in Nanotechnology (2022) Vol. 4
Open Access | Times Cited: 1

Structural basis for the broad and potent cross-reactivity of an N501Y-centric antibody against sarbecoviruses
Bo-Seong Jeong, Joon Young Jeon, Chih‐Jen Lai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 1

Computational redesign of Beta-27 Fab with substantially better predicted binding affinity to the SARS-CoV-2 Omicron variant than human ACE2 receptor
Wantanee Treewattanawong, Thassanai Sitthiyotha, Surasak Chunsrivirot
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access

Page 1

Scroll to top